Scholar Rock (SRRK) announced that Rebecca McLeod has been appointed to the newly created role of Chief Brand Officer and U.S. General Manager. In this role, she will be responsible for leading the anticipated U.S. commercial launch of apitegromab for patients with SMA – along with establishing the global apitegromab brand strategy and market positioning for Europe, Asia-Pacific and Latin America.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRRK:
- Scholar Rock Elects New Directors at Annual Meeting
- Scholar Rock’s Promising Earnings Call Highlights Apitegromab Progress
- Analyst Recommends ‘Buy’ for Scholar Rock Holdings Amid Promising Developments in Apitegromab for Neuromuscular Diseases
- Scholar Rock Reports Q1 2025 Financial Results
- Promising Growth Prospects for Scholar Rock: Buy Rating Backed by Apitegromab’s Potential and Strategic Milestones